Henry Ford Cancer - Detroit — Detroit, Michigan

Henry Ford Cancer - Detroit is a clinical research site located in Detroit, Michigan, United States 48282.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Henry Ford Cancer - Detroit has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC.

Sponsors: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), Crinetics Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer - Detroit?

Henry Ford Cancer - Detroit has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer - Detroit conducted?

Henry Ford Cancer - Detroit has 2 clinical trials on record, with 2 currently active. Their work covers Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC.

Is Henry Ford Cancer - Detroit accredited by Crixeo Health?

Henry Ford Cancer - Detroit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer - Detroit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.